Prazosin during threat discrimination boosts memory of the safe stimulus
Access DataFirst Author
Homan
Abstract
ID 179
Authors
Year
2017
DOI of Publication
Persistent Identifier to Dataset
Where was the data collected?
Icahn School of Medicine at Mount Sinai, USA
How to Cite
Homan, P., Lin, Q., Murrough, J. W., Soleimani, L., Bach, D. R., Clem, R. L., & Schiller, D. (2017). Prazosin during threat discrimination boosts memory of the safe stimulus. Learning & memory (Cold Spring Harbor, N.Y.), 24(11), 597–601. https://doi.org/10.1101/lm.045898.117
Participant Information
Participant Age
Participant Gender
Experimental Group
Placebo Group: - Administration of placebo 2h before acquisition Prazosin Group: - Administration of 3 mg Prazosin before acquisition (1 mg 2 h before acq., 2 mg 1.5 h before acq.)
Stimuli
Yes
Drug Administration
Conditioning Protocol
Differential
Instructions CS-US Contingencies
Uninstructed (whole exp)
Number of Different US
1
US Modality
electrotactile
Number of Different CS+
1
CS+ 1: Reinforcement Rate (%)
43
CS+ 2: Reinforcement Rate (%)
CS+ 3: Reinforcement Rate (%)
Number of Different CS-
1
CS Modality
visual
No
Data Collected During MRI
Physiological Measures
trialwise & untransformed
measured
Yes
Yes
Skin Conductance Response
No
No
Skin Conductance Level
No
No
Pupil Size
No
No
Fear Potentiated Startle/Startle EMG
No
No
Heart Rate
Ratings
No